A prospective, multi-center, non-comparative, open-label, post marketing surveillance (PMS) to evaluate safety and efficacy of Decellularized Dermis (DermACELL AWM�®) for the replacement of damaged skin in patients with Lower Extremity Ulcers, Traumatic Burns and Dehisced Surgical Wounds in clinical practice in India.
100 Clinical Results associated with PharmaLeaf India Private Limited
0 Patents (Medical) associated with PharmaLeaf India Private Limited
100 Deals associated with PharmaLeaf India Private Limited
100 Translational Medicine associated with PharmaLeaf India Private Limited